Cafepharma Today

January 30 2025 - Novo Nordisk commences fresh trials for CagriSema
Novo Nordisk commences fresh trials for CagriSema
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Sanofi plans €5 billion buyback, sees higher profit growth
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Tallying Harvard Medical School’s Drug-Industry Ties
WSJ Online
Tuesday, March 3, 2009 - 11:41am
tags:
pharma industry
Roche Gains as Genentech Talk Eases Price Concerns
Bloomberg
Tuesday, March 3, 2009 - 9:26am
tags:
Roche, buyouts, Genentech
Pfizer signs deal with Bausch & Lomb to co-promote several eye-care products in US
Yahoo/AP
Tuesday, March 3, 2009 - 9:25am
tags:
Pfizer, optical care, Bausch & Lomb
Par reports 4Q loss on restructuring, legal charge
Businessweek
Tuesday, March 3, 2009 - 8:59am
tags:
Par Pharmaceutical, earnings
Drug Cocktail May Slow Alzheimer's
WSJ Online
Tuesday, March 3, 2009 - 8:55am
tags:
Forest Labs, Alzheimer's disease, memantine, Namenda
Inspire Pharmaceuticals sets 2009 revenue outlook, cuts jobs to focus on key programs
Yahoo/AP
Tuesday, March 3, 2009 - 8:54am
tags:
Inspire, outlook, layoffs
Pfizer Expects To Become Top Drug Co In Japan After Merger
CNN Money
Tuesday, March 3, 2009 - 6:30am
tags:
Pfizer, Wyeth, Japan
Genentech May Produce as Many as 15 New Drugs by 2015
Bloomberg
Tuesday, March 3, 2009 - 6:28am
tags:
Genentech, pipelines, Roche, buyouts
Pfizer expands generic portfolio through Aurobindo deal
Marketwatch
Tuesday, March 3, 2009 - 6:27am
tags:
Pfizer, India, Aurobindo
Genentech: Roche Needs Us More
TheStreet.com
Monday, March 2, 2009 - 5:44pm
tags:
Genentech, Roche, buyouts
Lazard sees Amylin's exenatide as a blockbuster
Yahoo/AP
Monday, March 2, 2009 - 5:43pm
tags:
Amylin, exenatide, diabetes, Byetta, Eli Lilly
Options: Put Buyer in Johnson & Johnson
TheStreet.com
Monday, March 2, 2009 - 5:42pm
tags:
JNJ
New Use for Erbitux Stalled by FDA’s Data Request
WSJ Online
Monday, March 2, 2009 - 5:39pm
tags:
Erbitux, FDA, Eli Lilly, ImClone, Bristol-Myers Squibb
Optimer Pharma Beats 50-day MA
Yahoo/AP
Monday, March 2, 2009 - 1:06pm
tags:
Optimer
Genentech makes case for higher Roche offer
Yahoo/AP
Monday, March 2, 2009 - 1:04pm
tags:
Genentech, buyouts, Roche
[video] Genentech vs. Roche
Yahoo/CNBC
Monday, March 2, 2009 - 1:03pm
tags:
Genentech, Roche, buyouts
Pharma's Public Relations Bonus: Executive Pay
Motley Fool
Monday, March 2, 2009 - 12:49pm
tags:
executive pay, pharma industry
Most U.S. Flu Strains Resist Roche's Tamiflu, Study Says
WSJ Online
Monday, March 2, 2009 - 12:47pm
tags:
Roche, Flu, Tamiflu, RELENZA, GSK
The FDA's Infection
Forbes
Monday, March 2, 2009 - 12:46pm
tags:
FDA, antibiotics, Theravance, Pfizer, JNJ
PXSL: Files NDA w/FDA for Aridol(TM) Bronchial Challenge Test
Trading Markets
Monday, March 2, 2009 - 9:41am
tags:
Aridol, Pharmaxis, NDA, FDA

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information